Display options
Cite
Heigle B, Khan A, Ottwell R, et al. Use of exaggerated language in news stories to describe drugs for treatment of Alzheimer's disease. Alzheimers Dement (N Y). 2020;6(1):e12062doi: 10.1002/trc2.12062.
Heigle, B., Khan, A., Ottwell, R., & Vassar, M. (2020). Use of exaggerated language in news stories to describe drugs for treatment of Alzheimer's disease. Alzheimer's & dementia (New York, N. Y.), 6(1), e12062. https://doi.org/10.1002/trc2.12062
Heigle, Benjamin, et al. "Use of exaggerated language in news stories to describe drugs for treatment of Alzheimer's disease." Alzheimer's & dementia (New York, N. Y.) vol. 6,1 (2020): e12062. doi: https://doi.org/10.1002/trc2.12062
Heigle B, Khan A, Ottwell R, Vassar M. Use of exaggerated language in news stories to describe drugs for treatment of Alzheimer's disease. Alzheimers Dement (N Y). 2020 Aug 13;6(1):e12062. doi: 10.1002/trc2.12062. eCollection 2020. PMID: 32802935; PMCID: PMC7424254.
Copy Download .nbib Format: NLM
Share it on

Alzheimers Dement (N Y). 2020 Aug 13;6(1):e12062. doi: 10.1002/trc2.12062. eCollection 2020.

Use of exaggerated language in news stories to describe drugs for treatment of Alzheimer's disease.

Alzheimer's & dementia (New York, N. Y.)

Benjamin Heigle, Ali Khan, Ryan Ottwell, Matt Vassar

Affiliations

  1. Oklahoma State University Center for Health Sciences Tulsa Oklahoma USA.

PMID: 32802935 PMCID: PMC7424254 DOI: 10.1002/trc2.12062

[No abstract available.]

Keywords: Alzheimer's disease; Alzheimer's disease drug; Alzheimer's disease treatments; dementia; news media; sensationalism; superlatives

Conflict of interest statement

The authors declare no conflicts of interest.

References

  1. PLoS Med. 2008 May 27;5(5):e118 - PubMed
  2. Eur Heart J Cardiovasc Pharmacother. 2020 Feb 17;: - PubMed
  3. J Eur Acad Dermatol Venereol. 2020 Apr 20;: - PubMed
  4. J Gen Intern Med. 2020 Jun 30;: - PubMed
  5. JAMA Oncol. 2016 Jan;2(1):139-41 - PubMed

Publication Types